Literature DB >> 19486163

Resistance to bacitracin in Streptococcus pyogenes from oropharyngeal colonization and noninvasive infections in Portugal was caused by two clones of distinct virulence genotypes.

Renato Pires1, Dora Rolo, Rosario Mato, João Feio de Almeida, Christina Johansson, Birgitta Henriques-Normark, Ana Morais, António Brito-Avô, José Gonçalo-Marques, Ilda Santos-Sanches.   

Abstract

During 2000-2007 in Lisbon, we identified 45 bacitracin-resistant Streptococcus pyogenes isolates among 1629 isolates: 24 from oropharyngeal healthy carriers (out of 1026), 21 from patients with noninvasive infections (out of 559) and zero from invasive infections (out of 44). Forty-four of those isolates, mainly of colonization, are low-level bacitracin-resistant members of the cMLS(B)-macrolide-resistant and tetracycline-susceptible emm28/ST52 clone previously detected in Europe, but only among clinical samples. One high-level bacitracin-resistant isolate, associated with a tonsillitis/pharyngitis episode, is cMLS(B)-macrolide-resistant and tetracycline-resistant member of the emm74/ST120 lineage, which was not previously known to include bacitracin-resistant isolates. The bcrABDR operon encoding an ATP-binding cassette transporter in Enterococcus faecalis was not detected among these bacitracin-resistant S. pyogenes strains. Virulence profiling indicated that genes coding for exotoxins and superantigens seem to be clone specific. This study provides an increased knowledge about specific bacitracin-resistant S. pyogenes strains, which may be useful in future investigations aiming to understand the mechanism(s) leading to bacitracin resistance and the cause(s) for differences in colonization and/or dissemination potential.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19486163     DOI: 10.1111/j.1574-6968.2009.01642.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  7 in total

1.  Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.

Authors:  Renato Pires; Carmen Ardanuy; Dora Rolo; Ana Morais; António Brito-Avô; José Gonçalo-Marques; Josefina Liñares; Ilda Santos-Sanches
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

2.  Description of macrolide-resistant and potential virulent clones of Streptococcus pyogenes causing asymptomatic colonization during 2000-2006 in the Lisbon area.

Authors:  R Pires; D Rolo; A Morais; A Brito-Avô; C Johansson; B Henriques-Normark; J Gonçalo-Marques; I Santos-Sanches
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-21       Impact factor: 3.267

3.  In vitro activities of retapamulin and 16 other antimicrobial agents against recently obtained Streptococcus pyogenes isolates.

Authors:  Emilio Pérez-Trallero; Esther Tamayo; Milagrosa Montes; José M García-Arenzana; Victor Iriarte
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

4.  Molecular Cloning and Docking of speB Gene Encoding Cysteine Protease With Antibiotic Interaction in Streptococcus pyogenes NBMKU12 From the Clinical Isolates.

Authors:  Natesan Balasubramanian; Govintharaj Varatharaju; Vellasamy Shanmugaiah; Karuppiah Balakrishnan; Mandayam A Thirunarayan
Journal:  Front Microbiol       Date:  2018-08-07       Impact factor: 5.640

Review 5.  Topical (local) antibiotics for respiratory infections with sore throat: An antibiotic stewardship perspective.

Authors:  Sabiha Essack; John Bell; Douglas S Burgoyne; Martin Duerden; Adrian Shephard
Journal:  J Clin Pharm Ther       Date:  2019-08-13       Impact factor: 2.512

6.  Human group A streptococci virulence genes in bovine group C streptococci.

Authors:  Márcia G Rato; Ricardo Bexiga; Sandro F Nunes; Cristina L Vilela; Ilda Santos-Sanches
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

7.  Group A streptococci clones associated with invasive infections and pharyngitis in Portugal present differences in emm types, superantigen gene content and antimicrobial resistance.

Authors:  Ana Friães; Francisco R Pinto; Catarina Silva-Costa; Mario Ramirez; José Melo-Cristino
Journal:  BMC Microbiol       Date:  2012-11-27       Impact factor: 3.605

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.